Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myelomaJagadish Kummetha Venkata, Yubin Kang|Blood|2014Cited by 96
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without a t(11;14) translocationPasupathi Sundaramoorthy, Yubin Kang|Cancer Medicine|2018Cited by 22
Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressorShaima Jabbar, Yubin Kang|Experimental Hematology and Oncology|2022Cited by 17
The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitorsBarry Paul, Yubin Kang|Cancer Medicine|2020Cited by 15
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivoYonggang Sha, Yubin Kang|Cancer Letters|2022Cited by 12